Evaluating overall survival with abiraterone acetate compared to enzalutamide in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Real-world data from the Flatiron electronic health records database.

Authors: Daniel J. George, Jasmina I. Ivanova, Maelys Touya, Betty Thompson, Jonathan Assayag, Benjamin Li, Nikolaos Kountouris, Gordon Siu, Stephen J. Freedland

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17033

Source: Full article

---

Abstract

e17033